Furuzakura capsules 5mg, manufactured by Takeda Pharmaceutical, contain Fruquintinib. This medication is indicated for metastatic colorectal cancer and has a YJ code of 4291088M2020, standardized as 5mg per capsule.
Furuzakura capsules 5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
